Locally Advanced Gastric Cancer Clinical Trial
Official title:
Clinical Efficacy of Carrelizumab, Apatinib Mesylate, Albumin Paclitaxel Combined With Oxaliplatin and S-1 in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes--A Prospective, Multi-center, Randomized Controlled Study
To evaluate the clinical efficacy of camrelizumab, apatinib Mesylate and nab-paclitaxel combined with oxplatin and S-1 in the neoadjuvant treatment of locally advanced gastric cancer with different genotypes
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05545436 -
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03192735 -
Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer
|
Phase 2 | |
| Recruiting |
NCT03961373 -
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
|
Phase 3 | |
| Completed |
NCT02192983 -
A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
|
N/A | |
| Not yet recruiting |
NCT05610332 -
Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes
|
Phase 3 | |
| Recruiting |
NCT02855788 -
Metronomic Chemotherapy in Advanced Gastric Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT02365896 -
Comparison of Short Term Outcomes Between Totally Laparoscopic and Laparoscopy-Assisted Distal Gastrectomy With Billroth-II Reconstruction and D2 Lymphadenectomy for Locally Advanced Gastric Cancer
|
N/A | |
| Recruiting |
NCT05141747 -
A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.
|
Phase 2 | |
| Active, not recruiting |
NCT06277453 -
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
|
||
| Recruiting |
NCT05528367 -
Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
|
Phase 2 | |
| Recruiting |
NCT04792515 -
Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT06235164 -
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
|
||
| Recruiting |
NCT03322969 -
Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy
|
Phase 2 | |
| Recruiting |
NCT02302794 -
A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery
|
Phase 3 |